Hawkinson Russ
SEC CIK 1831807 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Sr. VP of Fin | 37.3K | $4,200 | — | 3 | 2020-12-08 | 2022-05-02 |
Most active insiders at SPRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chakma Justin | Chief Business Off | — | $1.48M |
| 2 | Karas Eric | Chief Commercial Off | — | $250.0K |
| 3 | Dorsey Brian | COO | — | $190.1K |
| 4 | Fitzpatrick Alexander A | CLO | — | $33.5K |
| 5 | Shah Pratik | Dir | — | — |
Hawkinson Russ made no open-market trades at SPRY in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-02 | SPRY | ARS Pharmaceuticals, Inc. | Hawkinson Russ | Sr. VP of Fin | A - Grant | $0.00 | +28.3K | 37.3K | +318% | $0 |
| A | 2022-02-24 | 2020-12-08 | SPRY | ARS Pharmaceuticals, Inc. | Hawkinson Russ | Sr. VP of Fin | P - Purchase | $21.00 | +200 | 200 | New | +$4,200 |
| D | 2022-02-02 | 2022-02-01 | SPRY | ARS Pharmaceuticals, Inc. | Hawkinson Russ | Sr. VP of Fin | A - Grant | $0.00 | +7,500 | 8,954 | +516% | $0 |
Purchase Sale Sale after option exercise All abbreviations